FASLG and cancer: Gemcitabine and oxaliplatin are known to activate intrinsic cell death mechanisms, following DNA damage, and cancer cells are known to upregulate MMP-7 to attenuate the Fas/FasL based extrinsic pathway for apoptosis [65] resulting in increased chemoresistance and evasion of death signaling.